Crossmark

Correspondence about the article “Effect of hydrocortisone on mortality in patients with severe community-acquired pneumonia. The REMAP-CAP corticosteroid domain randomized clinical trial”

Crossref DOI link: https://doi.org/10.1007/s00134-025-08003-y

Published Online: 2025-07-03

Published Print: 2025-09

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Dequin, Pierre-François https://orcid.org/0000-0003-4819-1769
Giraudeau, Bruno

Le Gouge, Amélie
License Information

Text and Data Mining valid from 2025-07-03

Version of Record valid from 2025-07-03
More Information

Article History

Accepted: 13 June 2025

First Online: 3 July 2025

Declaration

:

: PF Dequin reports funding for academic research projects from the French Ministry of Health and the companies Aerogen and Fisher and Paykel. He has received consulting fees from Aridis Pharmaceutical and conference attendance fees from AOP Health. B Giraudeau and A Le Gouge declare no conflicts of interest.

Document is current

Any future updates will be listed below